On Friday, it opened at $12, hit $20 and settled at $15.
if the volume returns today, MESO could close closer to $20.
US$1.2bn is considered a minnow in the pharma space, and this minnow is mixing it with the big boys.
Gilead has a market cap of US$100bn ... so if a pharma that is 1% of Gilead has a shot at the remedy to this global pandemic... sounds like a decent punt. Especially because heart failure and chronic lower back pain trials are about to read out in a couple of months.. and an fda approval later this year... multiple shots on goal.
MSB’s profile and technology is getting some attention at the exact time it needs it ... any deals or partnerships can only benefit from the publicity that MESO will get if the trial is successful.
MESO action tonight, page-474
-
- There are more pages in this discussion • 2,686 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |